SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
NextGen Healthcare, Inc. (NXGN) .
Criteria proven by this page:
- VALUE (50/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Analyst consensus target $24.00 (+0.3% upside) — modest upside expected.
Overall SharesGrow Score: 45/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
50/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NXGN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.46
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.04
Book Value / Share$0.00
Revenue / Share$9.75
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$24.00 (+0.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$0.26 |
$444.67M |
$15.68M |
3.5% |
| 2015 |
$0.45 |
$490.23M |
$27.33M |
5.6% |
| 2016 |
$0.09 |
$492.48M |
$5.66M |
1.1% |
| 2017 |
$0.29 |
$509.62M |
$18.24M |
3.6% |
| 2018 |
$0.04 |
$531.02M |
$2.42M |
0.5% |
| 2019 |
$0.38 |
$529.17M |
$24.49M |
4.6% |
| 2020 |
$0.11 |
$540.24M |
$7.5M |
1.4% |
| 2021 |
$0.14 |
$556.82M |
$9.52M |
1.7% |
| 2022 |
$0.02 |
$596.35M |
$1.62M |
0.3% |
| 2023 |
$-0.04 |
$653.17M |
$-2.65M |
-0.4% |
